Abstract-Preeclampsia is a life-threatening disorder characterized by maternal gestational hypertension and proteinuria that results from placental dysfunction. Placental abnormalities include abnormal syncytiotrophoblast and a 50% reduction in placental expression of the transcription factor Gcm1. In mice, homozygous deletion of Gcm1 prevents syncytiotrophoblast differentiation and is embryonic lethal. We used heterozygous Gcm1 mutants (Gcm1 ϩ/Ϫ ) to test the hypothesis that hypomorphic expression of placental Gcm1 causes defective syncytiotrophoblast differentiation and maternal and placental phenotypes that resemble preeclampsia. We mated wild-type female mice with Gcm1 ϩ/Ϫ fathers to obtain wild-type mothers carrying Ϸ50% Gcm1 ϩ/Ϫ conceptuses. Gcm1 ϩ/Ϫ placentas had syncytiotrophoblast abnormalities including reduced gene expression of Gcm1-regulated SynB, elevated expression of sFlt1, a thickened interhemal membrane separating maternal and fetal circulations, and electron microscopic evidence in syncytiotrophoblast of necrosis and impaired maternal-fetal transfer. Fetoplacental vascularity was quantified by histomorphometry and microcomputed tomography imaging. In Gcm1
P
lacental dysfunction is believed to be the major cause of one of the most common and serious complications of human pregnancy, preeclampsia (PE). 1 This potentially lifethreatening hypertensive disorder adversely impacts Յ5% of all pregnancies and has no known cure. In PE, growing evidence implicates abnormalities in syncytiotrophoblast (SynT) in the villous exchange region of the placenta. [1] [2] [3] [4] [5] [6] SynTs are thin, fetal-derived cells that lie between the maternal blood flowing through the villous exchange region of the placenta and the fetal blood flowing through fetal vessels in the highly vascularized villi. This surface is essential for fetomaternal communication and exchange and is formed through the differentiation of SynT from the underlying villous cytotrophoblast cells under the control of the transcription factor GCM1 (glial cells missing 1). 7 Gcm1 in the conceptus is almost exclusively expressed in a subset of trophoblast in the placenta 8, 9 and is a critical regulator of the SynT cell type. 10 In the PE placenta, Gcm1 expression is reduced by Ϸ50%, 4 as is expression of the immediate downstream target of Gcm1, 11 Syn-1. 5, 6 That SynT is abnormal and potentially causative in PE is supported by abnormal levels of SynTproduced factors, such as pregnancy-associated plasma protein A, human chorionic gonadotropin, and inhibin in maternal blood during early pregnancy in women at high risk for the later development of PE. 12, 13 When PE develops, the abnormal syncytial surface is prothrombotic, leading to infarctions within the intervillous space, 14 and is excessively shed as aponecrotic fragments into the maternal circulation 1, 3 ; both are believed to be factors contributing to clinical signs of disease. 1, 3 The availability of Gcm1 deletion mutants provides an opportunity to explore the function of Gcm1 in vivo. Homozygous deletion mutants show the critical importance of Gcm1; embryonic lethality results from absent SynT differentiation and failure to form the exchange region known as the labyrinth in mice. 15, 16 Relative to placental differences between species, the placentas of humans and mice are strongly similar, 17, 18 although differences exist. In both species, maternal blood perfuses an intervillous space lined by fetal-derived trophoblasts that encase the fetoplacental vasculature within the exchange region. In both species, Gcm1 is expressed in trophoblast cells differentiating into SynT. 19, 20 However, whereas humans have a single SynT layer, mice have 2 layers; SynT-II is adjacent to the fetal vasculature, and it is intimately connected to SynT-I via gap junctions and nutrient transporters 21, 22 and, unlike SynT-I, only SynT-II expresses Gcm1. 10 In humans, the SynT surface is fully exposed to maternal blood, whereas in mice the SynT-I surface is partially covered by a discontinuous layer of sinusoidal trophoblast giant cells (sTGCs). 23 Given the difficulty in establishing causal relationships in human studies, here we exploit similarities between humans and mice by using heterozygous Gcm1 deletion mutants to determine whether reduced Gcm1 expression in mice causes changes in trophoblast morphology, fetoplacental vascularity, and pregnancy outcomes that resemble PE in humans.
Materials and Methods
Mouse and human experiments were approved by institutional review committees. For complete methods please see the online-only Data Supplement.
Mouse Model
CD1 females mated to males with heterozygous deletion of Gcm1 (Gcm1 ϩ/Ϫ ) 15, 16 carried Ϸ50% Gcm1 ϩ/Ϫ and Ϸ50% wild-type conceptuses. Control pregnancies were CD1 females mated with CD1 males. At embryonic day 13.5 (E13.5) and E17.5, placentas were microdissected to remove decidual tissue and frozen for protein assays or fixed for histology. Others were microdissected to obtain labyrinth-enriched samples for mRNA quantification by quantitative RT-PCR (primers in Table S1 , available in the online-only Data Supplement).
Human Patients
Placental villous tissue and matched histological samples were obtained from a BioBank (http://biobank.lunenfeld.ca). Samples were from pregnancies with PE, intrauterine growth restriction (IUGR; and without PE), and from gestation-matched preterm controls (Table) . PE was diagnosed as new-onset gestational hypertension, proteinuria, and reversal of hypertension and proteinuria by 12 weeks postpartum. 24 IUGR was diagnosed as fetal sex and gestation-adjusted birth weights less than the third centile 25 and absent end-diastolic blood flow velocity in umbilical artery Doppler waveforms.
Histology and Imaging
In mice, images from midline placental sections were quantified by histomorphometry 26 to obtain areas of placental components or evaluated by transmission electron microscopy. Counts of Ki67 positive cells in the labyrinth excluded sinusoidal trophoblast giant cells. In humans, the proportion of fetoplacental vasculature in villi was quantified in hematoxylin-eosin-stained sections. Microcomputed tomography was used to quantify fetoplacental arteries and arterioles Ն50 m in diameter, as published. [27] [28] [29] Capillaries were examined in vascular corrosion casts as published. 17, 27 
Maternal Phenotypes
Arterial pressure in awake mice was measured by tail-cuff plethysmography, urine protein by the Bradford method, urine creatinine by the Jaffé reaction, and sFLT1 protein in maternal plasma by ELISA.
Statistical Analysis
Wild-type littermates from CD1ϫGcm1 ϩ/Ϫ matings were used as controls for Gcm1 ϩ/Ϫ conceptuses. Statistical significance (PϽ0.05) was determined using Wilcoxon sign-ranked test for quantitative RT-PCR data, 2-tailed Student t test (genotype effects), or 2-way ANOVA (genotype and gestation effects), followed by the Tukey post hoc test. Results show meanϮSE.
Results

Abnormal Trophoblast Differentiation
Gcm1 in mice is specifically expressed in the SynT-II layer of the labyrinth where it regulates expression of its downstream target, SynB 10 . In the Gcm1 ϩ/Ϫ labyrinth, expression of Gcm1 mRNA and protein was decreased by Ϸ50% relative to wild-type littermates ( Figure S1 in the online-only Data Supplement). Gcm1 deficiency resulted in a dysregulation of trophoblast differentiation as shown by an Ϸ35% decrease in SynB mRNA expression ( Figure S1A ), an Ϸ2-fold increase in cell proliferation within the labyrinth ( Figure S2 ), and prominent ultrastructural abnormalities of the 2 syncytial layers (SynT-I and SynT-II) at E17.5 ( Figure 1 ). There was evidence of necrosis 2, 30 in SynT-II including pale cytoplasm, numerous vacuoles, and swollen and degenerating mitochondria in transmission electron microscopy images ( Figure 1A through 1C). The Gcm1 ϩ/Ϫ SynT-I layer appeared to differentiate normally in that expression of its marker gene, SynA, was not significantly affected (1.0Ϯ0.2-and 1.3Ϯ0.3-fold change relative to wild-type littermates, at E13.5 and E17.5, respectively; PϾ0.05). Nevertheless, the SynT-I layer exhibited ultrastructural abnormalities, including increased electron density and the presence of large fluid-filled vacuoles ( Figure 1A and 1B). SynT-I and SynT-II appeared thicker in Gcm1 ϩ/Ϫ placentas compared with wild-type littermate controls at both E13.5 and E17.5 ( Figure 1A and 1B). In addition, loss of apical membrane integrity in focal areas of the sTGCs (in direct contact with maternal blood) was observed in transmission electron microscopy images of the Gcm1 ϩ/Ϫ placenta at E17.5 ( Figure 1D ).
Abnormal Placental Histomorphology and Vascularity
At E13.5, the Gcm1 ϩ/Ϫ labyrinth was significantly decreased in cross-sectional area, and there were significant increases in the proportion of maternal blood spaces and in the thickness of the interhemal membrane relative to wild-type littermates (Figure 2A through 2D ). There was also an increase in the area of clustered cuboidal cells within the Gcm1 ϩ/Ϫ labyrinth ( Figure 2C ). In contrast, at E17.5, Gcm1 ϩ/Ϫ placentas had a significantly higher proportion of fetal blood spaces in the labyrinth compared with wild-type littermates ( Figure 2G ).
The latter is consistent with increased fetoplacental vascularity at E15.5 in Gcm1 ϩ/Ϫ placentas, as shown by significant increases in the total number and length of arterial segments with diameters Ͼ50 m by microcomputed tomography ( Figure 3 ) and apparent increases in the density of capillaries in vascular casts and in histological sections ( Figure S3A  through S3C) .
Intriguingly, the mRNA and protein expression profile of VEGFA, a potent proangiogenic molecule thought to play an important role in placental angiogenesis, 31 demonstrated decreased expression across gestation within the Gcm1 
Fetal and Placental Growth
Despite pronounced abnormalities in trophoblast differentiation and placental morphology, Gcm1 ϩ/Ϫ conceptuses grew normally; at E17.5 there were no significant differences between fetal weights of Gcm1 ϩ/Ϫ (1.2Ϯ0.1 g) versus wildtype littermates (1.1Ϯ0.1 g) or in their placental weights (92Ϯ15 versus 90Ϯ10 mg, respectively). There was no evidence for an effect of paternal genotype on litter size or number of resorptions.
Clinical Signs of PE in Mothers
CD1 females mated with Gcm1 ϩ/Ϫ males carried litters in which Ϸ50% of conceptuses were Gcm1 ϩ/Ϫ . These mothers had significantly higher mean arterial pressure at E17.5 compared with CD1 females mated with CD1 males (118Ϯ2 versus 109.6Ϯ0.7 mm Hg, respectively; Figure 5A ). The increase in maternal pressure in late gestation was positively correlated with the number of Gcm1 ϩ/Ϫ pups within the litter (R 2 ϭ0.54; PϽ0.05; Figure 5B ). CD1 mothers carrying mixed litters did not have proteinuria in late gestation; they excreted 1.8Ϯ0.5 mg of protein per milligram of creatinine versus 2.1Ϯ0.7 mg of protein per milligram of creatinine in controls. As in human PE placentas, 32 the Gcm1 ϩ/Ϫ labyrinth demonstrated a 2-fold increase in sFlt1 mRNA expression relative to the wild-type littermate controls ( Figure 5C ). However, in contrast to human PE, 32 there was no significant increase in maternal plasma sFLT1 protein ( Figure 5D ).
Correlation Between GCM1 and Fetoplacental Vascularity in Humans
Human clinical outcomes for patients with PE, with IUGR, and for gestation-matched controls are shown in the Table. The proportion of fetal vascular space within the villous tissue of patients with PE was significantly elevated relative to gestation-matched controls and IUGR placentas (Table) . Across all of the groups, the proportion of fetal vascular space within villous tissue was negatively correlated with GCM1 protein expression (R 2 ϭϪ0.45; PϽ0.05; Figure 6 ).
Discussion
In the current study, hypomorphic expression of placental Gcm1 caused defective SynT differentiation and maternal and placental phenotypes resembling PE in humans. As anticipated, heterozygous Gcm1 gene deletion reduced placental Gcm1 expression by Ϸ50%, a decrement similar to that in human PE placentas. 4 SynT-II cells exhibited prominent abnormalities, including reduced expression of SynB and ultrastructural evidence of necrosis. 30 Both SynT-I and SynT-II appeared thickened and ultrastructurally abnormal. Nevertheless Gcm1 ϩ/Ϫ fetuses were normally grown. Similarly, fetuses are normally grown in the majority of PE pregnancies, 33 despite evidence of hypomorphic Gcm1 expression and SynT dysfunction. [1] [2] [3] [4] [5] [6] An unexpected and striking finding of the current study was increased fetoplacental . Expression of proangiogenic factors at embryonic day (E) 13.5 and E17.5. A, mRNA expression of Vegfa and Pgf in labyrinthenriched Gcm1 ϩ/Ϫ samples normalized using 3 housekeeping genes and expressed as a fold change relative to wild-type littermate controls (Wt; hashed line at 1.0). Vegfa mRNA was significantly reduced at E13.5 and E17.5 in Gcm1 ϩ/Ϫ , whereas Pgf mRNA was significantly increased at E13.5 only. B, Placental VEGFA protein by ELISA was significantly decreased at both ages. C, Placental PGF protein by ELISA was not significantly changed. Number of pregnancies for each gestational age and genotype was Nϭ6. *PϽ0.05.
the Gcm1-regulated fusogenic protein SynB and by prominent ultrastructural abnormalities that directly paralleled the described focal necrosis abnormalities observed in the SynT layer in human PE. 30, 34 SynT-II is tightly integrated with the adjacent SynT-I layer. SynT-I uniquely expresses Syncytin A (SynA). 10 We found that SynA expression was not altered in Gcm1 ϩ/Ϫ placentas suggesting normal differentiation of SynT-I, a nonGcm1-expressing cell type. 10 Similarly, no change in SynA expression was observed in homozygous Gcm1 knockout placentas. 10 Nevertheless, morphology of the SynT-I layer was markedly abnormal in Gcm1 ϩ/Ϫ placentas; transmission electron microscopy imaging showed that it appeared thicker, contained more electron dense material, and contained many large, fluidfilled vacuoles. SynT-I and SynT-II are intimately connected by gap junctions and ultimately function as a single syncytial layer across which maternal-fetal transfer occurs. 21, 22 Thus, it is likely that a primary limitation in transport across the abnormal SynT-II layer contributed to abnormal SynT-I morphology by impeding the egress of protein and vacuoles from SynT-I. Abnormal SynT-II in Gcm1 ϩ/Ϫ placentas additionally influenced the discontinuous sTGCs 23 that overlie SynT-I in the maternal blood spaces of the labyrinth. Apical membrane integrity of sTGC was lost in localized areas, and cytoplasmic cellular contents were visible within the adjacent maternal blood space. This was unexpected given that the sTGCs are only loosely connected to the underlying SynT-I layer through desmosomal attachments 23 and are not in direct contact with SynT-II cells. Nevertheless, results suggest that hypomorphic Gcm1 expression in the PE placenta in human pregnancy may play a similar causative role in promoting the shedding of placental debris into the maternal circulation. This debris is thought to be responsible, at least in part, for the widespread maternal endothelial dysfunction and hypertension in PE. 1, 2 In mice, sTGCs release hormones such as placental lactogen, into the maternal circulation, 10 so abnormalities observed in this cell type in the current study may also alter maternal responses to pregnancy by an endocrine mechanism.
A remarkable finding in the current study was that fetal growth was not compromised despite marked abnormalities in SynT-I, SynT-II, and sTGC cell morphology, as well as augmented interhemal membrane thickness. It is possible that normal fetal growth was protected by increased fetoplacental vascular density in the Gcm1 ϩ/Ϫ labyrinth. Increased fetoplacental vascularity may have been caused by feedback mechanisms invoked by impaired transfer caused by the thicker, malfunctioning fetal-maternal exchange barrier. However, abnormal SynT-I in SynA knockout placentas also causes abnormal interhemal membrane morphology, but in that case results in fetoplacental hypovascularity, fetal growth restriction, and fetal lethality by E13.5. 35 Furthermore, Gcm1 overexpression results in fetoplacental hypovascularity, leading to fetal growth restriction in late-gestation in mice. 36 Thus, it is more likely that dysregulated SynT-II differentiation directly influences fetoplacental vascularization through altered signaling to the adjacent fetal endothelial and mesenchymal cells. How angiogenesis is augmented in the face of decreased mRNA and protein expression of the potent proangiogenic factor VEGFA, increased mRNA expression of the antiangiogenic sFlt1, and only modest increases in PGF at E13.5 is not known. It is possible that alternate unidentified angiogenic mechanisms are activated within the Gcm1 ϩ/Ϫ placenta. The same paradox among villous trophoblast pathology, 2, 30, 36 high placental expression of the antiangiogenic sFlt1, 32 and augmented villous angiogenesis (current study) occurs in PE where the majority of women give birth to infants of normal weight. 33 Indeed, the current results in Gcm1 ϩ/Ϫ mice prompted the examination and discovery of a similar negative correlation between placental vascularity and GCM1 protein expression in placental biopsies from normal and pathological pregnancies (PE and IUGR). Thus, this mouse model provides an excellent opportunity to explore this apparent incongruity and to advance our understanding of the influence of SynT on fetoplacental vascularization.
Hypomorphic Gcm1 expression resulted in significantly increased maternal arterial pressure in late gestation, although how hypomorphic Gcm1 in SynT-II caused this change is not known. Mechanisms other than increased circulating sFLT1 must be driving maternal hypertension, because, despite increased placental mRNA expression of sFlt1 in the Gcm1 ϩ/Ϫ placenta, sFLT1 protein in the maternal circulation was not significantly elevated. Maternal proteinuria was also absent, suggesting that renal function was unimpaired. It is possible that placental debris from sTGC entered the maternal circulation and caused endothelial cell inflammation, increased peripheral vascular resistance, and hypertension (as in human PE 1,2 ), or that abnormal endocrine signals from the dysfunctional sTGC are responsible. The increase in arterial pressure in this mouse model was modest, and this could mean that, alone, the hypomorphic expression of Gcm1 in the placenta of women with PE is insufficient to completely explain their hypertension. This is consistent with evidence suggesting that a combination of placental dysfunction and underlying maternal predispositions to endothelial dysfunction may be required for PE in women. 37, 38 Alternatively, it is also possible that relatively mild maternal effects were observed, because not all of the conceptuses were Gcm1 ϩ/Ϫ ; this cannot be achieved in a wild-type mother by natural breeding, because Gcm1 deletion is homozygous lethal. Wild-type conceptuses may diminish maternal effects by effectively diluting circulating factors released by Gcm1 ϩ/Ϫ placentas and/or by releasing protective factors into the maternal circulation. Indeed, a positive correlation was observed when maternal arterial pressure was plotted against the number of Gcm1 ϩ/Ϫ conceptuses within the pregnancy. Interestingly, evidence supports a similar mechanism in human twin pregnancies complicated by IUGR where a healthy co-twin appears to be protective; PE affects 6.8% of singleton pregnancies complicated with IUGR versus 1.5% in twin pregnancies when only 1 twin has IUGR. 39 Thus, results of the current study show that hypomorphic Gcm1 expression in SynT can elevate maternal arterial pressure in late-gestation in mice. This means that hypomorphic placental Gcm1 expression may not just correlate with human PE but could also play a causative role in maternal hypertension, one of the hallmark signs of PE. This conclusion is supported by the recent identification of a fetal variant in the Gcm1 gene that is associated with gestational hypertension in human pregnancy. 40 
Perspectives
Hypomorphic placental Gcm1 expression caused dysregulated SynT-II differentiation, abnormal morphology and dysfunction of the interhemal membrane, and augmented fetoplacental vascularity, and caused maternal hypertension in late gestation. In addition, we showed in humans that there is a similar inverse correlation between fetoplacental vascularity of placental villi and Gcm1 expression. These results, therefore, support a role for reduced placental Gcm1 expression as a causative factor in defective SynT differentiation and maternal and placental phenotypes in PE in humans.
